Home
University of Bergen
Hilde Renate Engerud's picture

Hilde Renate Engerud

PhD Candidate
Department of Clinical Science
  • E-mailHilde.Engerud@uib.no
  • Phone+47 928 96 775
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Journal articles
  • Engerud, Hilde Renate; Hope, Kirsten Øvergaard; Berg, Hege Fredriksen; Fasmer, Kristine Eldevik; Tangen, Ingvild Løberg; Haldorsen, Ingfrid S.; Trovik, Jone; Krakstad, Camilla. 2019. Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer. PLoS ONE. 14:e0210585: 1-13. doi: 10.1371/journal.pone.0210585
  • Halle, Mari Kyllesø; Ojesina, Akinyemi I; Engerud, Hilde Renate; Woie, Kathrine; Tangen, Ingvild Løberg; Holst, Frederik; Høivik, Erling Andre; Kusonmano, Kanthida; Haldorsen, Ingfrid S.; Vintermyr, Olav Karsten; Trovik, Jone; Bertelsen, Bjørn; Salvesen, Helga; Krakstad, Camilla. 2017. Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study. American Journal of Obstetrics and Gynecology. 217: 432.e1-432.e17. doi: 10.1016/j.ajog.2017.05.068
  • Engerud, Hilde Renate Haugen; Tangen, Ingvild Løberg; Berg, Ansgar; Kusonmano, Kanthida; Halle, Mari Kyllesø; Øyan, Anne Margrete; Kalland, Karl-Henning; Stefansson, Ingunn; Trovik, Jone; Salvesen, Helga; Krakstad, Camilla. 2014. High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors. British Journal of Cancer. 111: 78-84. doi: 10.1038/bjc.2014.262
  • Halle, Mari Kyllesø; Krakstad, Camilla; Engerud, Hilde Renate Haugen; Bertelsen, Bjørn; Salvesen, Helga. 2014. Molecular profiling in fresh tissue with high tumor cell content promotes enrichment for aggressive adenocarcinomas in cervix. Pathology, Research and Practice. 210: 774-778. doi: 10.1016/j.prp.2014.07.002
  • Engerud, Hilde Renate Haugen; Krakstad, C; Berg, A; Tangen, IL; Kusonmano, K; Birkeland, E; Werner, HMJ; Wik, E; Akslen, LA; Oyan, AM; Petersen, K; Kalland, KH; Trovik, J; Salvesen, HB. 2013. HIGH LEVEL OF NUCLEAR HEAT-SHOCK FACTOR 1 (HSF1) ASSOCIATES WITH AGGRESSIVE DISEASE AND SUGGESTS TARGETS FOR THERAPY IN ENDOMETRIAL CARCINOMA. International Journal of Gynecological Cancer. 23. 1 pages.
  • Njølstad, Tormund Salvesen; Engerud, Hilde Renate H; Werner, Henrica Maria Johanna; Salvesen, Helga Birgitte; Trovik, Jone. 2013. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. Gynecologic Oncology. 131: 410-415. doi: 10.1016/j.ygyno.2013.08.032

More information in national current research information system (CRIStin)